Twitter Facebook LinkedIn

Our Members

Johnson & Johnson

About We believe transparency of clinical trial data advances science and medicine and is in the best interest of the people who use our pharmaceutical, medical device, and consumer products, as well as healthcare providers. As such, we support the overall principles of greater clinical trial data transparency, including registration and disclosure of clinical trial results in external registries, publication of results in peer-reviewed journals, and sharing of clinical study reports (CSRs) and de-identified participant-level data from clinical trials.
How we share on the AMR Register To obtain Johnson & Johnson Family of Companies’ AMR surveillance data for analysis, researchers should use the AMR Register platform to submit a request. The anonymized data will then be made available to the researcher to download. Data for ongoing surveillance programs will be updated annually.
Programs Listed for Sharing Johnson & Johnson Family of Companies’ AMR surveillance data available on the AMR Register:
• DREAM Study
What information will be provided Where available, the following data and information are provided for each dataset:
🗹 Raw dataset. This is the dataset containing the anonymized isolate level data collected during the study. The dataset can be downloaded.
🗹 Program description. Information about how the data were collected is provided on the program pages.
🗹 Links to Publications. Links to journal publications based on the data collected are provided on the program pages.
Questions or enquiries Please send any questions or enquiries to
Johnson & Johnson Register or Website